ARK Genomic Revolution ETF vs Baidu Inc — how do they compare? ARK Genomic Revolution ETF trades at $44.41, while Baidu Inc trades at $104.35 (market cap $36.18B). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Baidu Inc nearer its low. Which is the better fit depends on your goals.
| ARKG | BIDU | |
|---|---|---|
Sector | Sector/Thematic | Media |
52-Week High | $44.55 | $162.52 |
52-Week Low | $24.02 | $86.76 |
Market Cap | — | $36.18B |
Enterprise Value | — | $32.81B |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Baidu (BIDU) trades at $103.7, down 5.3% in the last session, reflecting bearish technical signals and recent earnings volatility. The stock shows weak profitability with a net margin of 1.02% and elevated P/E of 78.19, though it trades below book value. Recent news highlights autonomous vehicle testing in London and an upcoming Q2 2026 earnings report on August 18, 2026 (PRNewsWire, 2026-07-31).
Outlook is mixed: strong analyst buy consensus (75.47%) and a $169.80 price target suggest upside, but declining revenue, negative cash flows, and China market risks pose headwinds. AI initiatives offer growth potential, but investors face execution and macroeconomic uncertainties.
Trailing returns across standard periods
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →Baidu, Inc. operates an Internet search engine. The Company offers algorithmic search, enterprise search, news, MP3, and image searches, voice assistance, online storage, and navigation services. Baidu serves clients globally.
Read more on BIDU →